As aging has her experiencing estrogen loss and her MS, columnist Susan Payrovi evaluates her response to the changes she's ...

Using disease-modifying therapies in MS tends to reduce the risk of stroke, though effects vary depending on the type of DMT, ...

While there was more risk, most studies couldn't disentangle the effects of childhood adversity from other factors that may ...

Subtle symptoms of MS are often overlooked in patients with minimal disability, but clinical tools can help detect them early ...

Until her daughter left for college, columnist Leigh Anne Nelson didn't realize all the help she was getting. Now she knows.

MS patients on B-cell depleting therapies are still protected against COVID-19 risk due to greater anti-viral T-cell activity, a study found.

The Epstein-Barr virus — a well-established risk factor for MS — is able to alter the movements of immune cells, a new study ...

Cognitive symptoms, mood disorders, and fatigue manifest differently in relapsing-remitting vs. progressive forms of MS, a ...

MS-related cognitive impairments are often misperceived by others, columnist Desiree Lama writes, which can make a case of ...

For columnist Ben Hofmeister, living with MS isn't about viewing the glass as half-full or half-empty, but adopting a blend of outlooks.

Supervised at-home neural stimulation helped women with MS and cannabis use disorder decrease their cannabis intake and ...

Stem cells from donated placentas appear safe and may help ease secondary progressive MS, a small open-label Phase 1 clinical ...